Gov. JB Pritzker supports a proposal that would require pharmacy benefit managers to change how they do business.

Executive order on prescription drug pricing supports key drug industry efforts to weaken the Medicare negotiation program.

An EO signed on April 15th is a solid first step toward improving drug affordability without diminishing the hope of patients ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.

The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 7.85% ...

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of ...

The Anticoccidial Drugs Market plays a crucial role in the veterinary pharmaceutical industry, particularly in the management of coccidiosis, a parasitic disease that affects various animal species.

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

People taking GLP-1s consumed less processed food, although they still craved it. As a growing number of people using ...

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Incretin-based Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...